| Financial Year |
March 31 2023 |
| Monetary Funds |
3,334,381,886.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,001,504,308.56 |
| Accounts Receivable |
5,385,452,380.93 |
| Advances to Suppliers |
390,777,881.75 |
| Other Receivables |
134,446,718.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,472,657,617.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
367,304,688.85 |
| Total Current Assets |
18,691,152,077.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
225,337,617.17 |
| Investment Properties |
238,274,178.43 |
| Fixed Assetes |
20,563,097,728.79 |
| Under-construction Projects |
3,756,588,597.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,582,330,699.76 |
| R&D expenses |
320,149,706.27 |
| Goodwill |
48,265,219.55 |
| Long-Term Deferred and Prepaid Expenses |
121,891,867.58 |
| Deferred Income Tax Assets |
511,803,276.35 |
| Other Non-Current Assets |
225,266,710.89 |
| Sub-Total of Non-Current Assets |
28,059,712,097.83 |
| Total Assets |
46,750,864,175.15 |
| Short-Term Loans |
1,140,801,745.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,686,524,778.77 |
| Accounts Payable |
4,769,408,992.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
404,276,093.94 |
| Taxes Payable |
212,984,996.43 |
| Interest Payable |
-- |
| Dividend Payable |
16,918,883.21 |
| Other payables |
587,194,016.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,871,613,673.63 |
| Other Current Liabilities |
28,267,960.17 |
| Sub-Total of Current Liabilities |
13,965,326,642.25 |
| Long-term Loans |
5,977,919,261.43 |
| Bonds Payable |
1,821,836,712.30 |
| Long-Term Accounts Payable |
645,623,543.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
230,679,209.69 |
| Deferred Income Tax Liabilities |
147,450,325.61 |
| Other Non-Current Liabilities |
127,020,880.57 |
| Sub-Total of Non-Current Liabilities |
9,718,932,529.50 |
| Total Liabilities |
23,684,259,171.75 |
| Paid-In Capital(Or Share Stock) |
1,678,123,584.00 |
| Capital Surplus |
5,095,700,697.67 |
| Surplus Reserve |
665,292,288.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,241,771,447.80 |
| Minority Stockholder's Interest |
5,371,960,425.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,694,644,577.87 |
| Owner's Equity（Stockholder's Equity） |
23,066,605,003.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,750,864,175.15 |
